$BDX

AI 分析

生成於 May 11, 2026

AI Score
68/ 100
Hold$BDX

Becton Dickinson and Co.

$BDXNYSEHealthcareLarge-Cap

Becton Dickinson develops and sells medical technology products for medication management, diagnostics, and biosciences.

Market Cap
$68.0B
Revenue (TTM)
$20.2B
+4.0%
Net Income (TTM)
$1.8B
+6.0%
EPS (TTM)
$2.50
P/E Ratio
58.0
Dividend Yield
1.3%
52-Week Range
$215-$260
Beta
0.62
Dimension Scores
Fundamental
70
Technical
62
Sentiment
66
Risk / Reward
72
Momentum
58
FundTechSentRiskMome
Financial Health
Profitability
75moderate
Growth
61moderate
Liquidity
80strong
Solvency
72strong
Efficiency
68strong

Valuation, technical analysis, investment thesis, risk assessment and more for $BDX

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。